Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL - Low Density Lipoprotein Receptor Disorder”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Large-scale testing (Phase 3)Study completedNCT04681170
What this trial is testing

Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)

Who this might be right for
Homozygous Familial Hypercholesterolaemia (HoFH)
Amryt Pharma 46
Large-scale testing (Phase 3)Study completedNCT01078675
What this trial is testing

Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia

Who this might be right for
Familial Hypercholesterolaemia
AstraZeneca 315
Not applicableStudy completedNCT05628259
What this trial is testing

The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT

Who this might be right for
Type2 DiabetesSelf EfficacySelf Management+5 more
Pamukkale University 70
Not applicableLooking for participantsNCT04272697
What this trial is testing

EAS Familial Hypercholesterolaemia Studies Collaboration

Who this might be right for
Familial Hypercholesterolemia
Imperial College London 75,000
Not applicableUnknownNCT04897113
What this trial is testing

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Who this might be right for
HypercholesterolemiaHyperbilirubinemiaHyper IgE Syndrome+9 more
National Medical Research Center for Rehabilitation and Balneology 80
Not applicableStudy completedNCT05218005
What this trial is testing

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Who this might be right for
Familial HypercholesterolemiaFamilial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein BFamilial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation+5 more
University of British Columbia 140
Not applicableLooking for participantsNCT06960902
What this trial is testing

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

Who this might be right for
Familial HypercholesterolemiasAtherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital 600
Not applicableStudy completedNCT06910098
What this trial is testing

Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

Who this might be right for
LDL - Low Density Lipoprotein Receptor DisorderRosuvastatin
Central Park Medical College 195
Testing effectiveness (Phase 2)Study completedNCT01388816
What this trial is testing

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Who this might be right for
Type II Hyperlipidemia
Dr. Reddy's Laboratories Limited 176
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Not applicableStudy completedNCT01199094
What this trial is testing

Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5

Who this might be right for
Osteopetrosis
Odense University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00686010
What this trial is testing

Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

Who this might be right for
Type II Hyperlipidaemia
Japan Tobacco Inc. 198
Not applicableNot Yet RecruitingNCT07606118
What this trial is testing

An Observational Study to Evaluate Treatment Patterns in High, Very High and Extreme Cardiovascular Risk Patients With Hypercholesterolemia, Including Familial Hypercholesterolemia

Who this might be right for
HypercholesterolaemiaFamilial HypercholesterolaemiaCVD Risk
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 2,500
Not applicableUnknownNCT05638022
What this trial is testing

Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic

Who this might be right for
Familial Hypercholesterolaemia
Institute of Health Information and Statistics of the Czech Republic 10,000
Not applicableUnknownNCT03934320
What this trial is testing

Improving Identification of Familial Hypercholesterolaemia in Primary Care (FAMCAT)

Who this might be right for
Familial Hypercholesterolemia
University of Nottingham 400
Large-scale testing (Phase 3)Study completedNCT01763918
What this trial is testing

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Who this might be right for
Hyperlipidemia
Amgen 331
Large-scale testing (Phase 3)Not Yet RecruitingNCT07474649
What this trial is testing

Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Who this might be right for
Coronary AtherosclerosisMixed DyslipidemiaHypercholesterolemia
Daiichi Sankyo 103
Large-scale testing (Phase 3)Active Not RecruitingNCT07000136
What this trial is testing

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

Who this might be right for
Heterozygous Familial Hypercholesterolaemia
AstraZeneca 473
Large-scale testing (Phase 3)Ended earlyNCT01410383
What this trial is testing

Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care

Who this might be right for
Heterozygous Familial Hypercholesterolaemia
Karo Bio AB 236
Testing effectiveness (Phase 2)Study completedNCT00688896
What this trial is testing

Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia

Who this might be right for
Type II Hyperlipidemia
Akros Pharma Inc. 155
Next Page